Biomarkers of Kaposi sarcoma recrudescence in Zambia
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Biomarkers of Kaposi sarcoma recrudescence in Zambia
Principal Institution
University of Zambia
Principal Investigator(s) (PI)
Ngalamika, Owen
Project Contact Information
Email: owen_ngalamika@yahoo.com
Year(s) Awarded
2018–2023
Country
Zambia
Collaborators
University of Nebraska
NIH Partners
NCI
Project Description
This study is the first to prospectively investigate biomarkers of Kaposi sarcoma (KS) recrudescence or stable remission in a cohort of Zambian epidemic KS patients on antiretroviral therapy (ART) that initially achieved remission after chemotherapy.
Related World Regions / Countries
Related Global Health Research Topics